Whetstone Capital Advisors, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
Health Catalyst, Inc. 13D/A Amendment 2
HCAT · 42225T107
 4.5% 6/8/2026
Event 6/4/2026
Beachbody Company, Inc. 13G/A Amendment 2
BODI · 073463309
 2.4% 5/1/2026
Event 3/31/2026
Open Lending Corp 13G/A Amendment 1
LPRO · 68373J104
 3.2% 5/1/2026
Event 3/31/2026
Sera Prognostics, Inc. 13G/A Amendment 2
SERA · 81749D107
 8.6% 5/1/2026
Event 3/31/2026
Health Catalyst, Inc. 13D/A Amendment 1
HCAT · 42225T107
 8.2% 2/18/2026
Event 2/17/2026
Health Catalyst, Inc. 13D
HCAT · 42225T107
 7.4% 1/21/2026
Event 1/15/2026
Open Lending Corporation 13G
LPRO · 68373J104
 5.1% 1/16/2026
Event 12/31/2025
The Beachbody Company, Inc. 13G/A Amendment 1
BODI · 073463309
 6.8% 1/16/2026
Event 12/31/2025
Sera Prognostics, Inc. 13G/A Amendment 1
SERA · 81749D107
 9.2% 1/16/2026
Event 12/31/2025
Health Catalyst, Inc. 13G/A Amendment 1
HCAT · 42225T107
 5.3% 1/14/2026
Event 12/31/2025
The Beachbody Company, Inc. 13G
BODI · 073463309
 8.3% 9/8/2025
Event 6/30/2025
Sera Prognostics, Inc. 13G
SERA · 81749D107
 9.9% 9/8/2025
Event 6/30/2025
Health Catalyst, Inc. 13G
HCAT · 42225T107
 5.4% 9/8/2025
Event 6/30/2025
OptimizeRx Corporation 13D/A Amendment 2
OPRX · 68401U204
 8.2% 4/21/2025
Event 4/18/2025
OptimizeRx Corporation 13D/A Amendment 1
OPRX · 68401U204
 8.2% 3/10/2025
Event 3/6/2025
OptimizeRx Corporation 13D
OPRX · 68401U204
 8.2% 2/5/2025
Event 2/3/2025